ZoBio - Welcome

ZoBio is developing innovative methods using Nuclear Magnetic Resonance to screen compound libraries for binding to a broad range of pharmacological targets.

Our aim is to be capable of rapidly generating high affinity, high specificity lead compounds with optimal drug-like properties for targets with great pharmacological value but for which developing drugs using presently available technologies would be difficult or impossible.

 
 

Please have a look inside to learn
more about our technology and
how we can make it available to you.
The unique TINS ligand screening
station being developed by ZoBio.
    

[click to enlarge picture]
    
 
 
Latest news

ZoBio and BioFocus DPI announce marketing agreement

Leiden, NL and Saffron Walden, UK – Nov 13, 2008
Read more >

Fragment based screening at CRELUX
and ZoBio

Leiden, NL - Nov 9, 2008
Read more >

NewLink Genetics selects Pyxis Discovery and ZoBio

Leiden, NL - May 27,2008
Read more >


View all news items >>

ZoBio presents at various events

See eventlist >